Mergermarket surveyed 100 senior corporate and private equity executives from U.S. firms that had completed at least one healthcare deal in the past two years.
Here are seven statistics:
1. Move from fee-for-service to bundled/value-based payments: 19 percent
2. End of cost-sharing reduction payments to insurers: 18 percent
3. Repeal of the individual mandate: 16 percent
4. Possibility of new regulation to lower drug prices: 13 percent
5. Reduced Medicaid contributions to states: 13 percent
6. Uncertain future of the ACA: 11 percent
7. Reduced reimbursement on 340B qualified drugs: 10 percent
More articles on benchmarking:
Oversights & challenges in healthcare acquisitions — 11 statistics
5 main drivers of healthcare acquisitions
79% of firms will pursue alliances or JVs in the near future — 8 statistics
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.